RETA
Point72 Asset Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-568,151
| Closed | -$57.9M | – | 2293 |
|
|
2023
Q2 | $57.9M | Buy |
568,151
+204,051
| +56% | +$20.8M | 0.17% | 144 |
|
|
2023
Q1 | $33.1M | Buy |
+364,100
| New | +$33.1M | 0.1% | 234 |
|
|
2022
Q4 | – | Sell |
-1,810,647
| Closed | -$45.5M | – | 1486 |
|
|
2022
Q3 | $45.5M | Buy |
+1,810,647
| New | +$45.5M | 0.18% | 146 |
|
|
2021
Q2 | – | Sell |
-58,800
| Closed | -$5.86M | – | 1161 |
|
|
2021
Q1 | $5.86M | Buy |
58,800
+17,800
| +43% | +$1.77M | 0.03% | 513 |
|
|
2020
Q4 | $5.07M | Buy |
+41,000
| New | +$5.07M | 0.02% | 549 |
|
|
2020
Q3 | – | Sell |
-146,938
| Closed | -$22.9M | – | 1084 |
|
|
2020
Q2 | $22.9M | Sell |
146,938
-29,360
| -17% | -$4.58M | 0.15% | 183 |
|
|
2020
Q1 | $25.4M | Sell |
176,298
-52,002
| -23% | -$7.51M | 0.21% | 139 |
|
|
2019
Q4 | $46.7M | Sell |
228,300
-131,788
| -37% | -$26.9M | 0.25% | 111 |
|
|
2019
Q3 | $28.9M | Buy |
360,088
+42,788
| +13% | +$3.44M | 0.18% | 160 |
|
|
2019
Q2 | $29.9M | Buy |
317,300
+26,700
| +9% | +$2.52M | 0.16% | 145 |
|
|
2019
Q1 | $24.8M | Sell |
290,600
-10,600
| -4% | -$906K | 0.11% | 176 |
|
|
2018
Q4 | $16.9M | Sell |
301,200
-448,600
| -60% | -$25.2M | 0.08% | 254 |
|
|
2018
Q3 | $61.3M | Buy |
749,800
+550,706
| +277% | +$45M | 0.25% | 83 |
|
|
2018
Q2 | $6.96M | Buy |
+199,094
| New | +$6.96M | 0.03% | 425 |
|